X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1380) 1380
Publication (61) 61
Newspaper Article (33) 33
Book / eBook (24) 24
Book Review (18) 18
Book Chapter (12) 12
Conference Proceeding (10) 10
Newsletter (6) 6
Patent (5) 5
Dissertation (2) 2
Data Set (1) 1
Magazine Article (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
magnesium (643) 643
humans (456) 456
index medicus (394) 394
male (216) 216
female (214) 214
analysis (203) 203
animals (191) 191
calcium (188) 188
magnesium alloys (176) 176
corrosion (172) 172
adult (161) 161
materials science, multidisciplinary (152) 152
environmental sciences (145) 145
materials science, biomaterials (140) 140
alloys (135) 135
middle aged (131) 131
biocompatibility (129) 129
corrosion and anti-corrosives (128) 128
degradation (118) 118
magnesiumlegierung (110) 110
behavior (96) 96
aluminum (94) 94
engineering, biomedical (93) 93
zinc (92) 92
pharmacology & pharmacy (91) 91
coatings (90) 90
magnesium - chemistry (90) 90
adsorption (88) 88
magnesium base alloys (88) 88
iron (87) 87
magnesium hydroxide (86) 86
hydrogen-ion concentration (85) 85
microstructure (84) 84
aged (83) 83
mechanical properties (83) 83
surgical implants (82) 82
mechanical-properties (80) 80
aluminum hydroxide - adverse effects (79) 79
magnesium hydroxide - adverse effects (79) 79
korrosion (76) 76
phosphates (75) 75
drug combinations (74) 74
antacids - adverse effects (73) 73
biomedical materials (73) 73
hydroxides (73) 73
magnesium alloy (73) 73
aluminum hydroxide - therapeutic use (72) 72
corrosion resistance (72) 72
engineering, environmental (72) 72
biodegradation (70) 70
korrosionsbeständigkeit (70) 70
magnesium hydroxide - therapeutic use (69) 69
chemistry, physical (66) 66
rats (63) 63
in-vitro (62) 62
magnesium compounds (62) 62
removal (62) 62
x-ray diffraction (62) 62
antacids - therapeutic use (61) 61
engineering, chemical (61) 61
implants (61) 61
magnesium - pharmacology (61) 61
metallurgy & metallurgical engineering (61) 61
nanoparticles (61) 61
biomaterials (60) 60
bone (60) 60
chemistry (59) 59
copper (59) 59
magnesium - therapeutic use (59) 59
hydroxyapatite (58) 58
sodium (58) 58
kinetics (57) 57
physics, applied (57) 57
magnesium oxide (55) 55
biodegradability (53) 53
magnesium - blood (53) 53
biological products (52) 52
metals (52) 52
research (52) 52
magnesium - adverse effects (51) 51
surface properties (51) 51
implantat (49) 49
magnesium hydroxide - administration & dosage (49) 49
precipitation (49) 49
toxicity (49) 49
manganese (48) 48
oxidation (47) 47
adolescent (46) 46
materials testing (45) 45
mice (45) 45
water (45) 45
alloys - chemistry (44) 44
minerals (44) 44
protective coatings (44) 44
administration, oral (43) 43
corrosion behavior (43) 43
cytotoxicity (43) 43
materials science, coatings & films (43) 43
titanium (43) 43
chemistry, multidisciplinary (42) 42
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (10) 10
Engineering & Comp. Sci. - Stacks (5) 5
UofT at Mississauga - Stacks (2) 2
Chemistry (A D Allen) - Stacks (1) 1
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Engineering & Comp. Sci. - Reference (1) 1
Mt Sinai Hospital - Pathology (1) 1
Online Resources - Online (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1420) 1420
German (13) 13
French (10) 10
Russian (7) 7
Japanese (6) 6
Polish (3) 3
Spanish (3) 3
Chinese (2) 2
Italian (2) 2
Portuguese (2) 2
Bulgarian (1) 1
Czech (1) 1
Danish (1) 1
Korean (1) 1
Slovak (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane Database of Systematic Reviews, ISSN 1469-493X, 08/2016, Volume 2016, Issue 8, p. CD009118
Background Constipation within childhood is an extremely common problem. Despite the widespread use of osmotic and stimulant laxatives by health professionals... 
CONTROLLED-TRIAL | MAGNESIUM-HYDROXIDE | Dietary Fiber [adverse effects; therapeutic use] | Humans | Child, Preschool | Infant | PSYLLIUM FIBER | Osmosis | Mineral Oil [adverse effects; therapeutic use] | MEDICINE, GENERAL & INTERNAL | Polyethylene Glycols [adverse effects; therapeutic use] | POLYETHYLENE-GLYCOL 3350 | Child | Lactulose [adverse effects; therapeutic use] | HYDROLYZED GUAR GUM | PLUS ELECTROLYTES | Laxatives [adverse effects; therapeutic use] | LIQUID PARAFFIN | Constipation [drug therapy] | Magnesium Hydroxide [adverse effects; therapeutic use] | Randomized Controlled Trials as Topic | Defecation [drug effects; physiology] | CHRONIC FUNCTIONAL CONSTIPATION | Sugar Alcohols [adverse effects; therapeutic use] | Adolescent | DOUBLE-BLIND | RECTAL FECAL IMPACTION | Lactulose - adverse effects | Defecation - drug effects | Polyethylene Glycols - adverse effects | Laxatives - therapeutic use | Magnesium Hydroxide - adverse effects | Polyethylene Glycols - therapeutic use | Sugar Alcohols - therapeutic use | Laxatives - adverse effects | Sugar Alcohols - adverse effects | Magnesium Hydroxide - therapeutic use | Dietary Fiber - therapeutic use | Mineral Oil - adverse effects | Dietary Fiber - adverse effects | Mineral Oil - therapeutic use | Defecation - physiology | Constipation - drug therapy | Lactulose - therapeutic use
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 2008, Volume 130, Issue 1, pp. 86 - 94
Journal Article
Trends in Immunology, ISSN 1471-4906, 2010, Volume 31, Issue 3, pp. 103 - 109
Aluminium adjuvants potentiate the immune response, thereby ensuring the potency and efficacy of typically sparingly available antigen. Their concomitant... 
Allergy and Immunology | MAGNESIUM | CELLS | ACTIVATION | CYTOKINE PRODUCTION | HYDROXIDE ADJUVANT | MECHANISM | IMMUNE-RESPONSES | MONOCLONAL-ANTIBODY | IMMUNOLOGY | BRAIN | NALP3 INFLAMMASOME | Adjuvants, Immunologic - pharmacology | Aluminum Compounds - adverse effects | Reactive Oxygen Species - metabolism | Humans | Muscle, Skeletal - metabolism | Magnesium Compounds - immunology | Vaccines - metabolism | Adjuvants, Immunologic - adverse effects | T-Lymphocytes - drug effects | Adenosine Triphosphate - metabolism | Inflammation Mediators - metabolism | Aluminum Hydroxide - pharmacology | Adaptive Immunity - immunology | Phosphates - pharmacology | Magnesium Compounds - pharmacology | Phosphates - immunology | Aluminum Hydroxide - metabolism | Antigen-Presenting Cells - metabolism | Immunity, Innate - drug effects | Oxidation-Reduction | Phagocytes - drug effects | Antigen-Presenting Cells - drug effects | Vaccines - immunology | Inflammation - immunology | Aluminum Compounds - immunology | Phagocytes - metabolism | Phagocytes - immunology | Antigen-Presenting Cells - immunology | Inflammation - etiology | Aluminum Compounds - metabolism | Magnesium Compounds - metabolism | B-Lymphocytes - drug effects | Immunity, Innate - immunology | Extracellular Fluid - metabolism | Models, Immunological | Phosphates - metabolism | Adaptive Immunity - drug effects | Aluminum Hydroxide - adverse effects | Animals | B-Lymphocytes - immunology | Phosphates - adverse effects | Aluminum Hydroxide - immunology | T-Lymphocytes - immunology | Aluminum Compounds - pharmacology | Ligands | Immunization | Vaccines | Fluorides | Molecular weight | Clinical Medicine | Neurologi | Neurology | Medical and Health Sciences | Medicin och hälsovetenskap | Surgery | Klinisk medicin | Kirurgi
Journal Article
Journal of Pharmacy and Pharmacology, ISSN 0022-3573, 11/2016, Volume 68, Issue 11, pp. 1359 - 1365
Objectives Raltegravir is a human immunodeficiency virus (HIV)‐1 integrase strand transfer inhibitor currently marketed at a dose of 400 mg twice daily (BID).... 
interaction | pharmacokinetics | calcium carbonate | once‐daily | aluminium and magnesium hydroxide | once-daily | ACID-REDUCING AGENTS | THERAPY | VOLUNTEERS | PHARMACOLOGY & PHARMACY | HIV-INTEGRASE INHIBITOR | Raltegravir Potassium - adverse effects | Area Under Curve | Magnesium - administration & dosage | Humans | Middle Aged | Raltegravir Potassium - administration & dosage | Male | Metabolic Clearance Rate | Aluminum Hydroxide - administration & dosage | HIV Integrase Inhibitors - administration & dosage | Drug Interactions | Polypharmacy | Antacids - adverse effects | HIV Infections - diagnosis | Adult | Female | Calcium Carbonate - administration & dosage | Magnesium - adverse effects | Raltegravir Potassium - pharmacokinetics | Drug Administration Schedule | Administration, Oral | HIV Infections - virology | HIV Integrase Inhibitors - pharmacokinetics | Magnesium Hydroxide - adverse effects | Calcium Carbonate - adverse effects | Aluminum Hydroxide - adverse effects | Magnesium Hydroxide - administration & dosage | HIV Integrase Inhibitors - adverse effects | Raltegravir Potassium - blood | HIV Infections - drug therapy | HIV Integrase Inhibitors - blood | Antacids - administration & dosage | Drug Combinations | Urine | Antiviral agents | Analysis | Electrocardiogram | Calcium carbonate | Electrocardiography | Magnesium hydroxide | HIV (Viruses) | Human immunodeficiency virus--HIV | Antacids | Magnesium
Journal Article
Journal of Digestive Diseases, ISSN 1751-2972, 09/2013, Volume 14, Issue 9, pp. 463 - 468
Objective The aim of the study was to investigate whether hydrotalcite was comparable to esomeprazole, a proton pump inhibitor, in on‐demand therapy for... 
non‐erosive reflux disease | effectiveness | on‐demand therapy | gastroesophageal reflux | esomeprazole sodium | hydrotalcite | Gastroesophageal reflux | Esomeprazole sodium | Non-erosive reflux disease | Hydrotalcite | On-demand therapy | Effectiveness | RABEPRAZOLE | INFECTIONS | MAINTENANCE TREATMENT | MANAGEMENT | ACID | on-demand therapy | PROTON-PUMP INHIBITOR | CONSENSUS | FAILURE | GASTROESOPHAGEAL-REFLUX DISEASE | non-erosive reflux disease | NONEROSIVE REFLUX | GASTROENTEROLOGY & HEPATOLOGY | Proton Pump Inhibitors - economics | Anti-Ulcer Agents - economics | Humans | Magnesium Hydroxide - economics | Middle Aged | Esomeprazole - adverse effects | Male | Esomeprazole - economics | Esomeprazole - therapeutic use | Antacids - therapeutic use | Young Adult | Drug Costs - statistics & numerical data | Antacids - adverse effects | Gastroesophageal Reflux - economics | Antacids - economics | Adult | Female | Drug Therapy, Combination | Gastroesophageal Reflux - drug therapy | Aluminum Hydroxide - economics | Anti-Ulcer Agents - therapeutic use | Proton Pump Inhibitors - adverse effects | Anti-Ulcer Agents - adverse effects | Aluminum Hydroxide - therapeutic use | Treatment Outcome | Magnesium Hydroxide - adverse effects | Proton Pump Inhibitors - therapeutic use | Magnesium Hydroxide - therapeutic use | Aluminum Hydroxide - adverse effects | Cost-Benefit Analysis | Adolescent | Aged
Journal Article
Journal Article
Current Medical Research and Opinion, ISSN 0300-7995, 04/2008, Volume 24, Issue 4, pp. 1231 - 1235
Journal Article
Journal of Oncology Pharmacy Practice, ISSN 1078-1552, 12/2005, Volume 11, Issue 4, pp. 139 - 143
Purpose. The objectives of this study were (1) to describe the usage of topical oral solutions in patients experiencing chemotherapy-induced oral mucositis... 
Oncology pharmacists | Magic mouthwash